BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22845187)

  • 1. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.
    Hamza M; Doleys D; Wells M; Weisbein J; Hoff J; Martin M; Soteropoulos C; Barreto J; Deschner S; Ketchum J
    Pain Med; 2012 Oct; 13(10):1304-13. PubMed ID: 22845187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients.
    Veizi IE; Hayek SM; Narouze S; Pope JE; Mekhail N
    Pain Med; 2011 Oct; 12(10):1481-9. PubMed ID: 21943351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent intrathecal opioid escalation in chronic noncancer pain patients.
    Hayek SM; Veizi IE; Narouze SN; Mekhail N
    Pain Med; 2011 Aug; 12(8):1179-89. PubMed ID: 21810164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective, Randomized, Single-Blinded, Head-to-Head Long-Term Outcome Study, Comparing Intrathecal (IT) Boluses With Continuous Infusion Trialing Techniques Prior to Implantation of Drug Delivery Systems (DDS) for the Treatment of Severe Intractable Chronic Nonmalignant Pain.
    Hamza M; Doleys DM; Saleh IA; Medvedovsky A; Verdolin MH; Hamza M
    Neuromodulation; 2015 Oct; 18(7):636-48; discussion 649. PubMed ID: 26307558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term intrathecal drug administration for chronic nonmalignant pain.
    Duarte RV; Raphael JH; Sparkes E; Southall JL; LeMarchand K; Ashford RL
    J Neurosurg Anesthesiol; 2012 Jan; 24(1):63-70. PubMed ID: 21904220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
    Grider JS; Harned ME; Etscheidt MA
    Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up.
    Atli A; Theodore BR; Turk DC; Loeser JD
    Pain Med; 2010 Jul; 11(7):1010-6. PubMed ID: 20492572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of intrathecal opioids in chronic non-cancer pain.
    Roberts LJ; Finch PM; Goucke CR; Price LM
    Eur J Pain; 2001; 5(4):353-61. PubMed ID: 11743701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
    Kongkam P; Wagner DL; Sherman S; Fogel EL; Whittaker SC; Watkins JL; McHenry L; Lehman GA
    Am J Gastroenterol; 2009 May; 104(5):1249-55. PubMed ID: 19367269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management.
    Zin CS; Nissen LM; O'Callaghan JP; Moore BJ; Smith MT
    Pain Med; 2010 Apr; 11(4):550-61. PubMed ID: 20202139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
    Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.
    Du Pen S; Du Pen A; Hillyer J
    Pain Med; 2006; 7(1):10-5. PubMed ID: 16533191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
    Duse G; DaviĆ  G; White PF
    Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intrathecal bupivacaine in refractory chronic nonmalignant pain.
    Kumar K; Bodani V; Bishop S; Tracey S
    Pain Med; 2009; 10(5):819-28. PubMed ID: 19523032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive model for intrathecal opioid dose escalation for chronic non-cancer pain.
    Duarte RV; Raphael JH; Haque MS; Southall JL; Ashford RL
    Pain Physician; 2012; 15(5):363-9. PubMed ID: 22996848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term intrathecal infusion of opiates for treatment of failed back surgery syndrome.
    Lara NA; Teixeira MJ; Fonoff ET
    Acta Neurochir Suppl; 2011; 108():41-7. PubMed ID: 21107937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intraspinal infusions of opioids with a new implantable medication pump.
    Likar R; Spendel MC; Amberger W; Kepplinger B; Supanz S; Sadjak A
    Arzneimittelforschung; 1999 Jun; 49(6):489-93. PubMed ID: 10417863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
    Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
    Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of intrathecal droperidol as an excellent antiemetic in nonmalignant pain--a retrospective study.
    Ahmad-Sabry MH; Shareghi G
    Middle East J Anaesthesiol; 2012 Oct; 21(6):857-62. PubMed ID: 23634568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.